Companies are now offering prospective parents the ability to genetically "score" embryos for desirable traits, a development rapidly blurring the lines between science fiction and reality. This advanced technology, known as polygenic embryo selection, goes beyond screening for genetic diseases. It aims to predict a wide range of future traits, from intelligence to susceptibility to certain conditions.
While proponents, like Michigan State University professor Steve Hsu, see it as a business opportunity driven by parental interest, critics point to significant scientific limitations and profound ethical implications. The predictive accuracy of current polygenic scores is often unreliable, and some research suggests these scores can reflect social and economic circumstances as much as genetics. Furthermore, they tend to be less accurate for individuals not of European ancestry.
The unchecked advancement of this technology risks creating a societal division akin to the dystopian future depicted in "Gattaca." Concerns include parents placing undue expectations on genetically selected children, potential discrimination against those not selected, and the stigmatization of individuals deemed genetically inferior. History shows a disturbing pattern of genetic science being misused to legitimize harmful ideologies.
While other developed nations like the U.K., Germany, and France have banned polygenic embryo selection, the U.S. currently lacks comprehensive regulation. This absence of oversight allows companies to market services with questionable scientific backing and few repercussions for misleading claims. The lack of agreed-upon standards for scientific accuracy means that screening for conditions like schizophrenia could inadvertently pave the way for selection based on traits like intelligence, athleticism, or even skin tone.
Currently, the high cost of IVF and genetic testing makes this technology inaccessible to most Americans. However, as it improves and potentially becomes more affordable, existing social inequalities could translate into biological ones, further widening the gap between the wealthy and the less fortunate. Significant investment from tech leaders further underscores the industry's rapid growth and the urgency for regulatory frameworks.
Addressing the ethical and social questions surrounding trait selection, the potential for unreasonable expectations, and the risk of creating a genetic arms race is paramount. Regulation is not an impediment to progress but a necessity to ensure that advancements benefit society broadly and prevent division.